Quantitative exercise technetium-99m tetrofosmin myocardial tomography for the identification and localization of coronary artery disease

European Journal of Nuclear Medicine

Volumn 23, Issue 6, 1996, Pages 648-655

  Sullo, Pasquale ^a   Cuocolo, Alberto ^a,b   Nicolai, Emanuele ^a   Cardei, Stefania ^a   Nappi, Antonio ^a   Squame, Fiorenzo ^a   Covelli, Eugenio M ^a   Pace, Leonardo ^a   Salvatore, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Myocardial perfusion; Single photon emission tomography; Technetium 99m labelled agents

Indexed keywords

TECHNETIUM 99M; TETROFOSMIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOMOGRAPHY;

CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EXERCISE TEST; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029887075     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00834526     Document Type: Article

References (41)

1. Pohost GM, Zir LM, Moore LM, et al. Differentiation of transiently ischemic from infarcted myocardium by serial imging after a single dose of thallium 201. Circulation 1979; 55: 294-302.
2. Gibson RS, Watson DD, Craddock GB, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983; 68: 321-336.
3. Kottler TS, Diamond GA. Exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. Ann Intern Med 1990; 113: 684-702.
4. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with F-18 fluorodeoxyglucose. Circulation 1991; 83: 26-37.
5. Iskandrian A, Heo J, Nguyen T, Mercuro J. Myocardial imaging with Tc-99m teboroxime: technique and initial results. Am Heart J 1991; 121: 889-894.
6. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2 methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
7. Berman DS, Kiat H, Maddahi J. The new Tc-99m myocardial perfusion imaging agents: Tc-99m-sestamibi and Tc-99m-teboroxime. Circulation 1991; 84 (Suppl I): 7-21.
8. Kiat H, Maddahi J, Roy LT, Friedman J, Resser K, Berman DS. Comparison of technetium-99m methoxy isobutyl isonitrile with thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989; 117:1-11.
9. Kahn JK, McGhie I, Akers MS, et al. Quantitative rotational tomograhy with Tl-201 and Tc-99m 2-methoxy-isobutyl-isonitrile: a direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989; 79: 1282-1293.
10. Iskandrian AS, Heo J, Kong B, Lyons E, Marsch S. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. Am J Cardiol 1989; 64: 270-275.
11. Okada RD, Glover D, Gaffeny T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxypropyl isonitrile. Circulation 1988; 77: 491-498.
12. Kelly JD, Highley B, Archer CM, et al. New functional diphosphine complex of Tc-99m for myocardial perfusion imaging [abstract]. J Nucl Med 1989; 30: 773.
13. Smith FW, Smith T, Gemmell HG, et al. Phase I study of Tc-99m diphosphine (P53) for myocardial imaging [abstract]. J Nucl Med 1991; 32: 967.
14. Lahiri A, Highley B, Crawley JWC, et al. Novel functionalized diphosphine complexes of Tc-99m for myocarcdial imaging in man [abstract]. J Nucl Med 1989; 30: 818.
15. Sridhara BS, Braat S, Itti R, Rigo P, Cload P, Lahiri A. Early and late myocardial imaging with a new technetium 99m diphosphine (PPN1011) in coronary artery disease [abstract]. J Am Coll Cardiol 1992; 19: 202A.
16. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with Tc-99m tetrofosmin versus Tl-201 in coronary artery disease. Am J Cardiol 1993; 72: 1015-1019.
17. Hingley B, Smith SW, Smith T, et al. Technetium-99m-1,2-bis(bis(2-ethoxyethyl)phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion agent. J Nucl Med 1993; 34: 30-38.
18. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin myocardial perfusion imaging agent: implications for one-day imaging protocol. J Nucl Med 1993; 34: 1254-1259.
19. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979; 300: 1350-1358.
20. Cuocolo A, Soricelli A, Pace L, et al. Adenosine technetium-99m methoxy isobutyl isonitrile myocardial tomography in patients with coronary artery disease: comparison with exercise. J Nucl Med 1994; 35: 1110-1115.
21. Borrello JA, Clinthorne NH, Rogers WL, Thrall JH, Keyes JW. Oblique-angle tomography: a reconstructing algorithm for transaxial tomographic data. J Nucl Med 1981; 22: 471-473.
22. Kelly JD, Forster AM, Highly B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-227.
23. Mahmarian JJ, Verani MS. Exercise thallium-201 perfusion scintigraphy in the assessment of coronary artery disease. Am J Cardiol 1991; 67: 2D-11D.
24. Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial. J Am Coll Cardiol 1992; 20: 265-275.
25. Verani MS. Myocardial perfusion imaging versus two-dimensional echocardiography: comparative value in the diagnosis of coronary artery disease. J Nucl Cardiol 1994; 1: 399-414.
26. De Pasquale EE, Nody AC, DePuey EG, et al. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation 1988; 77: 316-327.
27. Mahmarian JJ, Boyee TM, Goldberg RK, Cocanougher MK, Roberts R, Verani MS. Quantitative exercise thallium-201 single-photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol 1990; 15: 318-329.
28. Iskandrian AS, Heo J, Kong B, Lyons E. Effects of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989; 14: 1477-1486.
29. Tamaki N, Takahashi N, Kawamoto M, Torizuka T, Tadamura E, Yomekura Y, Okuda K, Nohara R, Sassayama S, Konishi J. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35: 594-600.
30. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m-tetrofosmin. J Nucl Med 1993; 34: 1478-1484.
31. Zaret BL, Rigo P, Wackers FJT, et al. Myocardial perfusion imaging with Tc-99m tetrofosmin. Comparison to Tl-201 imaging and coronary angiography in a phase III multicenter trial. Circulation 1995; 91: 313-319.
32. Gould KL, Kelley KO. Experimental validation of quantitative coronary arteriography for determining prrssure-flow characteristics of coronary stenosis. Circulation 1982; 66: 930-937.
33. Marcus ML, Skorton DJ, Johnson MR, et al. Visual estimates of percent diameter coronary stenosis: "a battered gold standard". J Am Coll Cardiol 1988; 11: 882-888.
34. Marcus ML, Harrison DG, White CH, et al. Assessing the physiological significance of coronary obstruction in patients: importance of diffuse, undetected atherosclerosis. Prog Cardiovasc Dis 1988; 31: 39-56.
35. Rocco TP, Dilsizian V, McKusick KA, Fishman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest "reinjection" imging for the detection of viable myocardium. Am J Cardiol 1990; 66: 158-163.
36. Schelbert HR. Myocardial ischemia and clinical applications of positron emission tomography. Am J Cardiol 1989; 64: 46E-53E.
37. Verani MS, Mahmarian JJ, Hixon JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990; 82: 80-87.
38. Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium-201 single photon emission computed tomography (SPECT) myocardial perfusion imaging. J Am Coll Cardiol 1992; 19: 248-257.
39. Tartagni F, Dondi M, Limonetti P, et al. Dipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: comparison with thallium-201 stress-rest study. J Nucl Med 1991; 32: 369-376.
40. Marwick T, D'Hondt AM, Boudhin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy or both? J Am Coll Cardiol 1993; 22: 159-167.
41. Cuocolo A, Santomauro M, Pace L, et al. Comparison between exercise and trans-oesophageal atrial pacing in patients with coronary artery disease: technetium-99m sestamibi simultaneous evaluation of ventricular function and myocardial perfusion. Eur J Nucl Med 1992; 19: 119-124.